The European Society of Endocrinology (ESE) has issued updated treatment guidelines for adults with chronic hypoparathyroidism, introducing changes such as…
Articles by Marisa Wexler, MS
The approved therapy Yorvipath (palopegteriparatide) can improve kidney function in adults with hypoparathyroidism within months of initiating treatment,…
People who develop chronic hypoparathyroidism following surgery are at high risk of kidney problems and infections, and they also…
Biotech company Septerna is currently conducting preclinical tests to identify a lead experimental therapy for hypoparathyroidism, with the…
Treatment with the investigational therapy encaleret normalized calcium levels for most people with chronic hypoparathyroidism in a small proof-of-principle…
People with long-lasting hypoparathyroidism after thyroid surgery are at risk of having deteriorating kidney function, according to a study…
A Phase 2 clinical trial testing MBX 2109 in people with chronic hypoparathyroidism has finished enrolling participants, according to…
Long-lasting hypoparathyroidism following surgery is associated with more hospitalizations and higher healthcare-related medical costs compared with temporary hypoparathyroidism after…
Even with conventional treatment, health complications including the formation of calcium deposits in the brain, cataracts in the eyes, and…
The U.S. Food and Drug Administration (FDA) has given fast track designation to eneboparatide, an experimental treatment for hypoparathyroidism…